After eight years of research on rats fed APM, Italian scientist Morando Soffritti and his research team came to the conclusion EoACA[pounds sterling]that aspartame
could have carcinogenic effects,EoACA[yen] and asserted that aspartame
raises the risk of malignant tumors and cancer in rats.
The evaluation also concluded that using aspartame
in the context of a reduced calorie diet does not affect weight and may be associated with increased weight loss.
The agency also says there have been five previously conducted large, epidemiologic studies on cancer and aspartame
that found no association.
is the methylester of N-alpha-aspartyl-Lphenylalanine, a polypeptide widely employed as an artificial, intense synthetic sweetener, having none or insignificant caloric values and a sweeting power higher than that of sucrose.
It had never been associated with taking aspartame
before, and in fact was not listed on the symptom checklist given the patients during the study.
It showed a dose-related increase in the incidence of various malignant tumors in female rats fed aspartame
from 8 weeks of age until natural death.
The FDA approved aspartame
in 1981, after reviewing studies on lab animals that showed aspartame
did not cause cancer or lead to any other adverse health effects.
Tiene un valor calorico similar al azucar (4 kcal/g), pero las cantidades usadas son bastante pequenas como para considerar al aspartame
esencialmente libre de calorias.
is the sweetener used in such products as Equal, NutraSweet and others.
confirms previous study conclusions that there is no link between aspartame
consumption and leukemias, lymphomas, and brain tumours.
A large, new test in rats suggests that the artificial sweetener aspartame
may be a carcinogen.